Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02236130Terminated
Randomised, single-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by University of Mississippi Medical Center. Primary endpoint: Total Hydrocodone Dose at day 8. Started Jun 2014; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02236130.